These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K. Br J Surg; 2019 Mar; 106(4):419-426. PubMed ID: 30507040 [Abstract] [Full Text] [Related]
3. Laparoscopy-assisted versus open surgery for gastrointestinal stromal tumors of jejunum and ileum: perioperative outcomes and long-term follow-up experience. Wan P, Li C, Yan M, Yan C, Zhu ZG. Am Surg; 2012 Dec; 78(12):1399-404. PubMed ID: 23265132 [Abstract] [Full Text] [Related]
4. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection. Guérin A, Sasane M, Keir CH, Gauthier G, Macalalad AR, Wu EQ, Conley AP. JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106 [Abstract] [Full Text] [Related]
6. Surgical therapy for gastrointestinal stromal tumours of the upper gastrointestinal tract. Das A, Wilson R, Biankin AV, Merrett ND. J Gastrointest Surg; 2009 Jul; 13(7):1220-5. PubMed ID: 19370382 [Abstract] [Full Text] [Related]
7. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate. Wang AY, Ahmad NA, Zaidman JS, Brensinger CM, Lewis JD, Long WB, Kochman ML, Ginsberg GG. Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483 [Abstract] [Full Text] [Related]
8. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Jakob J, Mussi C, Ronellenfitsch U, Wardelmann E, Negri T, Gronchi A, Hohenberger P. Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573 [Abstract] [Full Text] [Related]
9. Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry. Sato S, Tsujinaka T, Masuzawa T, Yamamoto K, Takahashi T, Yamashita Y, Fujita J, Takagi M, Hirota S, Nishida T. Surg Today; 2017 Jan; 47(1):58-64. PubMed ID: 27194124 [Abstract] [Full Text] [Related]
10. Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial. Majer IM, Gelderblom H, van den Hout WB, Gray E, Verheggen BG. J Med Econ; 2013 Sep; 16(9):1106-19. PubMed ID: 23808902 [Abstract] [Full Text] [Related]
14. Gastrointestinal stromal tumours: incidence, recurrence and mortality. A decade of patients from a New Zealand tertiary surgical centre. Kirkpatrick J, Wang Y, Tu'inukuafe J, Chao P, Robertson J, Koea J, Srinivasa S. ANZ J Surg; 2024 Sep; 94(9):1556-1562. PubMed ID: 39148403 [Abstract] [Full Text] [Related]
16. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Novitsky YW, Kercher KW, Sing RF, Heniford BT. Ann Surg; 2006 Jun; 243(6):738-45; discussion 745-7. PubMed ID: 16772777 [Abstract] [Full Text] [Related]
17. Laparoscopic versus open resection of gastrointestinal stromal tumors: survival outcomes from the NCDB. Inaba CS, Dosch A, Koh CY, Sujatha-Bhaskar S, Pejcinovska M, Smith BR, Nguyen NT. Surg Endosc; 2019 Mar; 33(3):923-932. PubMed ID: 30171396 [Abstract] [Full Text] [Related]
20. Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour. D'Ambrosio L, Palesandro E, Boccone P, Tolomeo F, Miano S, Galizia D, Manca A, Chiara G, Bertotto I, Russo F, Campanella D, Venesio T, Sangiolo D, Pignochino Y, Siatis D, De Simone M, Ferrero A, Pisacane A, Dei Tos AP, Aliberti S, Aglietta M, Grignani G. Eur J Cancer; 2017 Jun; 78():122-132. PubMed ID: 28448856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]